The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis
- 1 March 1994
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 88 (3) , 203-211
- https://doi.org/10.1016/s0954-6111(05)80348-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inhaled drugs and the lungClinical and Experimental Allergy, 1991
- Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.Thorax, 1990
- Dilution of nebulised aerosols by air entrainment in childrenThe Lancet, 1990
- Long‐term tobramycin aerosol therapy in cystic fibrosisPediatric Pulmonology, 1989
- Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosisPediatric Pulmonology, 1989
- Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.Thorax, 1988
- Characteristics of Nebulizers Used in the Treatment of AIDS-Related Pneumocystis Carinii PneumoniaJournal of Aerosol Medicine, 1988
- A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosisRespiratory Medicine, 1987
- Quantitative Deposition of Aerosolized Gentamicin in Cystic FibrosisAmerican Review of Respiratory Disease, 1987
- Evaluation of jet nebulisers for use with gentamicin solution.Thorax, 1985